Your browser doesn't support javascript.
Side effects following first dose of COVID-19 vaccination in Ho Chi Minh City, Vietnam.
Nguyen, Si Van; Nguyen, Bay Thi; Duong, Huong Nguyen Viet; Lenh, Phong Thanh; Tran, Kien Trung; Tran, Hoa Minh; Nguyen, Thanh Cong; Nguyen, Dung Phuong; Ta, My Ngoc; Trieu, Nhut Nguyen Minh; Nguyen, Nam Ba; Tran, Hung Quang; Tran, Son Thanh; Rai, Raghu; Pham, An Le.
  • Nguyen SV; Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Nguyen BT; School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Duong HNV; Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Lenh PT; Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Tran KT; School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Tran HM; Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Nguyen TC; Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Nguyen DP; Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Ta MN; Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Trieu NNM; Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Nguyen NB; Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Tran HQ; Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Tran ST; School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Rai R; School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam.
  • Pham AL; School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Hum Vaccin Immunother ; 19(1): 2176066, 2023 12 31.
Article in English | MEDLINE | ID: covidwho-2274103
ABSTRACT
Vaccines are strongly recommended globally as an effective measure to prevent serious illness from and spread of COVID-19. Concerns about safety following vaccination continue to be the most common reason that people do not accept the vaccine. This retrospective study was carried out on 4341 people who received the first dose of ChAdOx1 nCoV-19, BBIBP-CorV, or mRNA-1273 vaccine at Jio Health Clinic in Ho Chi Minh City, Vietnam. Post-injection side effects were either reported by participants or actively collected by health care staff by means of telemedicine. Local side effects were reported by 35.5% of all individuals, with pain being the most common symptom (33.3%). Systemic side effects were reported by 44.2% of individuals, with fever (25.3%) and fatigue (21.4%) being the most common. Age ≤60 years, female gender, and ChAdOx1 nCoV-19 were significant independent risk factors for both local and systemic side effects, while a history of allergy was significant as a risk factor for local side effects. A total of 43 individuals (1.0%) reported concerning symptoms of rare severe complications, which were addressed and treated by physicians via Jio Health app.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Female / Humans / Middle aged Country/Region as subject: Asia Language: English Journal: Hum Vaccin Immunother Year: 2023 Document Type: Article Affiliation country: 21645515.2023.2176066

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Female / Humans / Middle aged Country/Region as subject: Asia Language: English Journal: Hum Vaccin Immunother Year: 2023 Document Type: Article Affiliation country: 21645515.2023.2176066